These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 23123438)

  • 1. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL; Lee EH; Castaneda A; Klima R; Date E
    Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
    Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
    Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
    Braker C; Yariv S; Adler R; Badarny S; Eisenberg E
    Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of PrabotulinumtoxinA (Nabota
    Kim DY; Kim JM
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30177597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 3 needle sizes for trigger point injection in myofascial pain syndrome of upper- and middle-trapezius muscle: a randomized controlled trial.
    Yoon SH; Rah UW; Sheen SS; Cho KH
    Arch Phys Med Rehabil; 2009 Aug; 90(8):1332-9. PubMed ID: 19651267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study.
    Freund BJ; Schwartz M
    J Rheumatol; 2000 Feb; 27(2):481-4. PubMed ID: 10685817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
    Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
    Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial.
    Marco E; Duarte E; Vila J; Tejero M; Guillen A; Boza R; Escalada F; Espadaler JM
    J Rehabil Med; 2007 Jul; 39(6):440-7. PubMed ID: 17624477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
    Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
    J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.
    Nicol AL; Wu II; Ferrante FM
    Anesth Analg; 2014 Jun; 118(6):1326-35. PubMed ID: 24842179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
    Ojala T; Arokoski JP; Partanen J
    Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
    Desai MJ; Shkolnikova T; Nava A; Inwald D
    Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
    Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B
    Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
    Porta M
    Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on botulinum toxin A injections of trigger points for myofascial pain.
    Zhou JY; Wang D
    Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A; Barnes M; Comiskey C
    Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.